Submission for OMB Review; Comment Request; Reinstatement of OMB No. 0925-0601/exp. 02/28/2010, Request for Human Embryonic Stem Cell Line To Be Approved for Use in NIH Funded Research, 11185 [2010-5020]
Download as PDF
<![CDATA[
11185
Federal Register / Vol. 75, No. 46 / Wednesday, March 10, 2010 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Type of respondents
Demonstrators .............................................................................................................................
Demonstrators .............................................................................................................................
Demonstrators .............................................................................................................................
Demonstrators .............................................................................................................................
Observers ....................................................................................................................................
Observers ....................................................................................................................................
Observers ....................................................................................................................................
Observers ....................................................................................................................................
Dated: March 4, 2010.
Maryam Daneshvar,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2010–5156 Filed 3–9–10; 8:45 am]
Centers for Medicare & Medicaid
Services; Delegation of Authority
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Submission for OMB Review;
Comment Request; Reinstatement of
OMB No. 0925–0601/exp. 02/28/2010,
Request for Human Embryonic Stem
Cell Line To Be Approved for Use in
NIH Funded Research
ACTION:
Correction notice.
erowe on DSK5CLS3C1PROD with NOTICES
On March 2, 2010 the National
Institutes of Health published a notice
in the Federal Register (75 FR 9418)
with a 30-day comment period seeking
public comment for an information
collection entitled ‘‘Request for Human
Embryonic Stem Cell Line to be
Approved for Use in NIH Funded
Research’’.
In the second paragraph of the notice
entitled, ‘‘Proposed Collection,’’ the
annual reporting burden reflected in the
notice is corrected to read: ‘‘Estimated
Number of Respondents: 100; Estimated
Number of Responses per Respondent:
1; Average Burden Hours Per Response:
3; and Estimated Total Annual Burden
Hours Requested: 300. The estimated
annualized cost to respondents is
$10,500.’’
All other information in the notice is
correct and remains unchanged.
Dated: March 2, 2010.
Mikia Currie,
Office of Policy for Extramural Research
Administration, OD, National Institutes of
Health.
[FR Doc. 2010–5020 Filed 3–9–10; 8:45 am]
BILLING CODE 4140–01–P
VerDate Nov<24>2008
15:07 Mar 09, 2010
Jkt 220001
Office of the Secretary
Notice is hereby given that I have
delegated to the Administrator, Centers
for Medicare & Medicaid Services
(CMS), or his or her successor, the
authorities currently vested in the
Secretary under section 1135 [42 U.S.C.
1320b–5] of Title XI of the Social
Security Act, and as may hereafter be
amended, to temporarily waive or
modify requirements during certain
emergencies or disasters that are related
to Medicare, Medicaid, and the
Children’s Health Insurance Programs as
they pertain to the mission of CMS.
The authorities under section 1135
[42 U.S.C. 1320b–5] of the Social
Security Act, and as may hereafter be
amended, may be re-delegated.
Limitations
1. The authority to make the initial
decision to invoke the waiver
authorities under section 1135 [42
U.S.C. 1320b–5] upon the occurrence of
the two conditions precedent specified
in section 1135(g) [42 U.S.C. 1320b–
5(g)] is excluded from this delegation
and is reserved by me.
2. The following authorities under
section 1135 [42 U.S.C. 1320b–5] of the
Social Security Act, and as may
hereafter be amended, are excluded
from this delegation of authority:
—Section 1135(b)(7) pertaining to
sanctions and penalties that arise from
noncompliance with certain
requirements of regulations
promulgated under section 264(c) of the
Health Insurance Portability and
Accountability Act of 1996 (HIPAA) [42
U.S.C. 1320d–2 note]. The authority to
waive the HIPAA regulations at 45 of
the Code of Federal Regulations, Part
164 will continue to be held by me.
—Section 1135(d) to provide a
certification and advance written notice
PO 00000
Frm 00082
Fmt 4703
Sfmt 4703
Number of
responses per
respondent
30
30
30
30
170
170
170
170
Average
burden per
response
(in hours)
1
1
1
1
1
1
1
1
15/60
15/60
15/60
3
15/60
15/60
15/60
3
to Congress at least two days before
exercising the authority with respect to
an emergency area is reserved by me.
—Section 1135(f) to report to Congress
regarding the approaches used to
accomplish the purposes described in
section 1135(a) [42 U.S.C. 1320b–5] of
the Social Security Act, including an
evaluation of such approaches and
recommendations for improved
approaches should the need for such
emergency authority arise in the future
is reserved by me.
3. The authorities under section 1135
[42 U.S.C. 1320b–5] shall be exercised
under the Department’s policy on
regulations and the existing delegation
of authority to approve and issue
regulations.
I hereby affirm and ratify any actions
taken by the Administrator, CMS, or his
or her subordinates, which involved the
exercise of the authorities under section
1135 [42 U.S.C. 1320b–5] delegated
herein prior to the effective date of this
delegation of authority.
This delegation of authority is
effective immediately.
Authority: 44 U.S.C. 3101.
Kathleen Sebelius,
Secretary.
[FR Doc. 2010–4992 Filed 3–9–10; 8:45 am]
BILLING CODE 4120–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Center for Substance Abuse
Prevention; Notice of Cancellation of
Meeting
Pursuant to Public Law 92–462,
notice is hereby given of a cancellation
of the March 8, 2010 meeting of the
Substance Abuse and Mental Health
Services Administration (SAMHSA)
Drug Testing Advisory Board (DTAB).
Public notice was given in the Federal
Register on February 19, 2010 (Volume
E:\FR\FM\10MRN1.SGM
10MRN1
]]>Agencies
[Federal Register Volume 75, Number 46 (Wednesday, March 10, 2010)]
[Notices]
[Page 11185]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-5020]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Submission for OMB Review; Comment Request; Reinstatement of OMB
No. 0925-0601/exp. 02/28/2010, Request for Human Embryonic Stem Cell
Line To Be Approved for Use in NIH Funded Research
ACTION: Correction notice.
-----------------------------------------------------------------------
On March 2, 2010 the National Institutes of Health published a
notice in the Federal Register (75 FR 9418) with a 30-day comment
period seeking public comment for an information collection entitled
``Request for Human Embryonic Stem Cell Line to be Approved for Use in
NIH Funded Research''.
In the second paragraph of the notice entitled, ``Proposed
Collection,'' the annual reporting burden reflected in the notice is
corrected to read: ``Estimated Number of Respondents: 100; Estimated
Number of Responses per Respondent: 1; Average Burden Hours Per
Response: 3; and Estimated Total Annual Burden Hours Requested: 300.
The estimated annualized cost to respondents is $10,500.''
All other information in the notice is correct and remains
unchanged.
Dated: March 2, 2010.
Mikia Currie,
Office of Policy for Extramural Research Administration, OD, National
Institutes of Health.
[FR Doc. 2010-5020 Filed 3-9-10; 8:45 am]
BILLING CODE 4140-01-P
